Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
769.450.1%
QQQ
717.500.2%
BTC/USD
79975.010.1683%
DIA
532.880.22%
GLD
406.530.06%
TLT
82.240.04%

OKYO Pharma Ltd

OKYONASDAQ
Trade with Public
Trade with Public
$1.57
0.021.29%
At close: Sep 4, 5:00 PM EST
$1.54
-0.03-1.91%
After Hours: Sep 4, 7:39 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

OKYO Pharma Analyst Price Targets

Wall Street analyst price targets and consensus rating for OKYO Pharma (OKYO).

Price Target Range — 10 Quarters

Analyst Consensus — 3 Analysts

3Buy
Consensus RatingBuy# Analysts3Avg. Consensus PT$6Upside to Avg. PT+268.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Jul 13, 2026HC Wainwright & Co.Yi ChenPT CutBuy$7→$5
Feb 20, 2026Piper SandlerBiren AminInitiateOverweight$7
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on OKYO Pharma, Lowers Price Target to $5

HC Wainwright & Co. analyst Yi Chen maintains OKYO Pharma (NASDAQ:OKYO) with a Buy and lowers the price target from $7 to $5.
Benzinga Newsdesk

This Pfizer Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Friday

Avi Kapoor

PRO
Piper Sandler Initiates Coverage On OKYO Pharma with Overweight Rating, Announces Price Target of $7

Piper Sandler analyst Biren Amin initiates coverage on OKYO Pharma (NASDAQ:OKYO) with a Overweight rating and announces Price Target of $7.
Benzinga Newsdesk

PRO
B. Riley Securities Initiates Coverage On OKYO Pharma with Buy Rating, Announces Price Target of $5

B. Riley Securities analyst William Woods initiates coverage on OKYO Pharma (NASDAQ:OKYO) with a Buy rating and announces Price Target of $5.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on OKYO Pharma, Maintains $7 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates OKYO Pharma (NASDAQ:OKYO) with a Buy and maintains $7 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on OKYO Pharma, Maintains $7 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates OKYO Pharma (NASDAQ:OKYO) with a Buy and maintains $7 price target.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved